Regenerative medicine (RM) is one of the most promising fields of regenerative medicine, with regenerative ophthalmology (RO) being one of the most active domains. The ability of revolutionary therapies to treat a number of disorders, ranging from AMD to congenital degenerations, is being explored. Regenerative ophthalmology (RO) strives to restore function by employing biomaterials, cells, and bioactive substances to replace or regenerate tissues and organs. These unique therapeutic techniques have the potential to improve the effectiveness and efficiency of ocular disease management. With the advancement of tissue engineering tools, RO researchers have focused their attention on the regeneration of lost or injured eye tissues as a new way to cure visual impairment and blindness caused by ocular degenerative disorders, trauma, or infection.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Targeting immunological pathways in Behcets uveitis
Hashim Butt, Bolton Royal Hospital, United Kingdom
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom
Title : Optimizing astigmatism management in refractive cataract surgery
Shadrokh Nabili, University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Title : Blood sugar measurement in acute anterior uveitis a life saving link
Shie Wei Chan, Manchester Royal Eye Hospital, United Kingdom